Thiol Oxidation and Loss of Mitochondrial Complex I Precede Excitatory Amino Acid-Mediated Neurodegeneration

Human ingestion of “chickling peas” from the plantLathyrus sativus, which contains an excitatory amino acid, l-BOAA (l-β-N-oxalylamino-l-alanine), leads to a progressive corticospinal neurodegenerative disorder, neurolathyrism. Exposure to l-BOAA, but not its optical enantiomer d-BOAA, causes mitochondrial dysfunction as evidenced by loss of complex I activity in vitro in male mouse brain slices and in vivo in selected regions of mouse CNS (lumbosacral cord and motor cortex). Loss of complex I activity in lumbosacral cord after l-BOAA administration to mice was accompanied by concurrent loss of glutathione. The inhibited complex I activity in mitochondria isolated from lumbosacral cord of animals treated with l-BOAA rebounded after incubation with the thiol-reducing agent dithiothreitol, indicating that oxidation of protein thiols to disulfides was responsible for enzyme inhibition. The inhibition of complex I could be abolished by pretreatment with antioxidant thiols such as glutathione ester and α-lipoic acid. Chronic treatment of male mice, but not female mice, withl-BOAA resulted in loss of complex I activity and vacuolation and dendritic swelling of neurons in the motor cortex and lumbar cord, paralleling the regionality of the aforementioned biochemical effects on CNS mitochondria. These results support the view that thiol oxidation and concomitant mitochondrial dysfunction (also implicated in other neurodegenerative disorders), occurring downstream of glutamate receptor activation by l-BOAA, are primary events leading to neurodegeneration. Maintenance of protein thiol homeostasis by thiol delivery agents could potentially offer protection against excitotoxic insults such as those seen withl-BOAA.

[1]  M. Rudra,et al.  Inhibition of Tyrosine Aminotransferase by β‐N‐Oxalyl‐l‐α,β‐Diaminopropionic Acid, the Lathyrus sativus Neurotoxin , 1997 .

[2]  F. Holsboer,et al.  Neuroprotection against oxidative stress by estrogens: structure-activity relationship. , 1997, Molecular pharmacology.

[3]  S. Rao,et al.  Inhibition of tyrosine aminotransferase by beta-N-oxalyl-L-alpha,beta-diaminopropionic acid, the Lathyrus sativus neurotoxin. , 1997, Journal of neurochemistry.

[4]  J. Rothstein,et al.  Therapeutic horizons for amyotrophic lateral sclerosis , 1996, Current Opinion in Neurobiology.

[5]  A. F. Schinder,et al.  Mitochondrial Dysfunction Is a Primary Event in Glutamate Neurotoxicity , 1996, The Journal of Neuroscience.

[6]  I. Reynolds,et al.  Mitochondrial Depolarization in Glutamate-Stimulated Neurons: An Early Signal Specific to Excitotoxin Exposure , 1996, The Journal of Neuroscience.

[7]  A. Ludolph,et al.  Toxic models of upper motor neuron disease , 1996, Journal of the Neurological Sciences.

[8]  S. Kulkarni,et al.  N‐Methyl‐d‐Aspartate Receptor Participation in Parkinson's Disease, a Neurodegenerative Disorder , 1995, Annals of the New York Academy of Sciences.

[9]  B. Slusher,et al.  Centrally-administered AMPA antagonists increase locomotion in parkinsonian rats , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[10]  N. Hattori,et al.  Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. , 1995, Biochimica et biophysica acta.

[11]  L. R. Hill,et al.  Carbidopa/levodopa and selegiline do not affect platelet mitochondrial function in early parkinsonism , 1995, Neurology.

[12]  H. Reichmann,et al.  Electron transport chain defects in Alzheimer's disease. , 1994, Neurology.

[13]  L. Chang,et al.  Neuronal ultrastructural abnormalities in a patient with frontotemporal dementia and motor neuron disease. , 1995, Dementia.

[14]  L. Scorrano,et al.  The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. Increase of the gating potential by oxidants and its reversal by reducing agents. , 1994, The Journal of biological chemistry.

[15]  C. Filley,et al.  Electron transport chain defects in Alzheimer's disease brain , 1994, Neurology.

[16]  V. Ravindranath,et al.  l-BOAA induces selective inhibition of brain mitochondrial enzyme, NADH-dehydrogenase , 1993, Brain Research.

[17]  J. Walker,et al.  NADH:ubiquinone oxidoreductase from bovine mitochondria. cDNA sequence of a 19 kDa cysteine-rich subunit. , 1991, The Biochemical journal.

[18]  S. Shankar,et al.  A simple and inexpensive slicer for preparation of brain slices , 1991, Journal of Neuroscience Methods.

[19]  P. Spencer,et al.  Lathyrism in rural northwestern Ethiopia: a highly prevalent neurotoxic disorder. , 1990, International journal of epidemiology.

[20]  J. Coyle,et al.  Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[21]  V. Ravindranath,et al.  Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress. , 1990, Biochemical and biophysical research communications.

[22]  J. Parks,et al.  Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.

[23]  D. Roy,et al.  β‐N‐Oxalylamino‐L‐Alanine Action on Glutamate Receptors , 1989, Journal of neurochemistry.

[24]  T. Murphy,et al.  Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress , 1989, Neuron.

[25]  D. J. Reed,et al.  Retention of oxidized glutathione by isolated rat liver mitochondria during hydroperoxide treatment. , 1988, Biochimica et biophysica acta.

[26]  P. Nunn,et al.  Inhibition of [3H]α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding by the excitotoxin β-N-oxaly-L-α,β-diaminopropionic acid , 1988 .

[27]  P. Nunn,et al.  Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. , 1987, Science.

[28]  Q. Mohammad,et al.  Lathyrism , 1939, The Lancet.

[29]  P. Spencer,et al.  Specific antagonism of behavioral action of “uncommon” amino acids linked to motor‐system diseases , 1987, Synapse.

[30]  A. Ludolph,et al.  LATHYRISM: EVIDENCE FOR ROLE OF THE NEUROEXCITATORY AMINOACID BOAA , 1986, The Lancet.

[31]  S. Gibson,et al.  Photosensitization of mitochondrial cytochrome c oxidase by hematoporphyrin derivative and related porphyrins in vitro and in vivo. , 1983, Cancer research.

[32]  P. Nunn,et al.  The neurolathyrogen, β-N-oxalyl-L-α,β-diaminopropionic acid, is a potent agonist at ‘glutamate preferring’ receptors in the frog spinal cord , 1981, Brain Research.

[33]  D. Cohn,et al.  Human neurolathyrism, a follow-up study of 200 patients. Part I: Clinical investigation. , 1981, Schweizer Archiv fur Neurologie, Neurochirurgie und Psychiatrie = Archives suisses de neurologie, neurochirurgie et de psychiatrie.

[34]  S. Rao ENTRY OF β‐OXALYL‐l‐α,β‐DIAMINOPROPIONIC ACID, THE LATHYRUS SATIVUS NEUROTOXIN INTO THE CENTRAL NERVOUS SYSTEM OF THE ADULT RAT, CHICK AND THE RHESUS MONKEY , 1978 .

[35]  Y. Hatefi,et al.  Preparation and properties of succinate: ubiquinone oxidoreductase (complex II). , 1978, Methods in enzymology.

[36]  A. Hirano,et al.  The central nervous system in a cast? of neurolathyrism , 1977, Neurology.

[37]  A. Hirano,et al.  The central nervous system in a case of neurolathyrism. , 1977, Neurology.

[38]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[39]  F. Tietze Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. , 1969, Analytical biochemistry.

[40]  T. King [40] Preparations of succinate—cytochrome c reductase and the cytochrome b-c1 particle, and reconstitution of succinate-cytochrome c reductase , 1967 .

[41]  P. Adiga,et al.  The Isolation and Characterization of β-N-Oxalyl-L-α,β-Diaminopropionic Acid: A Neurotoxin from the Seeds of Lathyrus sativus* , 1964 .